Subject: BN
Jim, getting back to brass tacks.

I recently watched the Brookfield presentations and the management state the valuation at present is a compelling opportunity over the next 5 years.

This is one you've held before as have I. (Before split) what do you think about Baybrooks post on valuation on the BN board and how the market values the company?

I notice chick Akre bought a while back and he likes compounders.

I think Baybrook might be right!